Loxo Oncology Inc. (NASDAQ:LOXO)
Old Forum Content for LOXOMake a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- efrain007: $LOXO wicked volatile and thin, but trying to break out of a squeeze today. Watching for a good close.
- efrain007: $LOXO testing high
- efrain007: $LOXO setting up nice
- ROSEY: @efrain007 $LOXO Thanks for mentioning.
- DrScience: $LOXO reported bigger loss than expected, though CEO Josh Bliekner, MD characterized the quarter as "productive." Main takeaway from the press release (no conference call) was NO capital raising anticipated through late 2018, and FDA grant of Breakthrough Therapy Designation to LOXO-101. Stock popped right up to resistance, retested, and now settling around $27.50. Set your alerts for $28.50 breakout.
- DrScience: $LOXO up 11% today after FDA granted Breakthrough Therapy Designation for LOXO-101 “for the treatment of unresectable or metastatic solid tumors with NTRK-fusion proteins in adult and pediatric patients who require systemic therapy and who have either progressed following prior treatment or who have no acceptable alternative treatments.”
$IRMD, $ITCI, $LOXO, $LXFT, $MANH, $NBIX,
$NDRM, $NHTC, $NTES, $NVRO, $OLED, $OME,
$OPHT, $PFNX, $PRTA, $PTLA, $QUNR, $RARE,
$RGR, $RNG, $RVNC, $SKX, $STMP, $TREE, $TYL, $W
Current IPOs I own: $AAOI $ATRA $BFAM $CARA $CDK $CHRS $CMRX $CONE $DPLO $EGRX $FCB $GLOB $HUBS $IBP $INCR $INGN $INOV $LOXO $PRAH $PRTA $Q $RDUS $SAGE $SEDG $STRP $TWOU $ZIOP
IPOs I'm watching: $ADMS $AFMD $ANET $AXTA $BLUE $CLLS $CYBR $DBVT $ERI ...
$AAOI $BFAM $CARA $CHRS $CMRX $DBVT $DPLO $EGRX $ERI $GLOB $GWB $HAWK $IBP $JRVR $LOXO $NCLH $OPB $Q $RH $TWOU
Here's my notes on the non-obvious ones:
AVOL - leases commercial aircraft. PE 9, PEG 0.36
CONE - data center real estate
DBVT - Epicuta ...
- highroller: $LOXO-Looks like this trade may be over?
|Stock Price||$USD 75.07|
Loxo Oncology Inc is a biopharmaceutical company. It is engaged in the development of selective medicines for patients with genetically defined cancers.Request Video of LOXO
Already a member? Sign in here.
- March 7th, 2018 - 2017 Q4 Earnings
- $USD 44.99 64.10%
- $USD 9.54 60.30%
- $USD 5.55 46.10%
- $USD 23.43 -69.85%
- $USD 25.56 -59.39%
- $USD 12.95 -56.61%
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 51,500 stock analysis videos
- Access an ever expanding library (51,500) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!